101 
Market Cap
Stock Chart
CathRx - 30 day Poll
Recent BLOGS About CathRx Add New
Latest Company News
|
CathRx Limited Announces Change In Voting Power Of PFM Cornerstone Limited
Reuters Key Development - Jul 12, 2010 |
|
CathRx Limited Announces Holding Interest Of UBS AG And Related Bodies Corporate
Reuters Key Development - Jun 30, 2010 |
|
CathRx Limited Signs Master Partnership Supply Agreement With Pioneer Medical Devices For European Union
Reuters Key Development - Jun 28, 2010 |
|
CathRx Limited Announces Holding Interest Of CM Capital Investments Pty Ltd
Reuters Key Development - Jun 18, 2010 |
|
CathRx Limited Announces Change In Voting Power Of PFM Cornerstone Limited
Reuters Key Development - Apr 23, 2010 |
Website
Videos related to CathRx
Company Profile
Finances:
Originally sponsored by tier 1 Australian Venture Capital firms.
Cash as of 1st December 2010: $5.015M
CathRx’s loss for the half-year ended 31 December 2009 was $5,785,122 compared to a loss of $7,100,918 for the corresponding half-year period ended 31 December 2008.
Sales growth in Europe continued with sales in 2H FY 2010 ($294,408) greater than the whole of FY 2009 ($124,254).
Background:
CathRx Ltd is a specialist Australian medical device company focusing on the development and commercialisation of a range of innovative cardiac catheters for use in the diagnosis and treatment of electrical problems of the heart known as cardiac arrhythmias.
The Company is listed on the Australian Securities Exchange where it is traded under the symbol CXD. It's head office, laboratory and manufacturing facilities are based at Homebush Bay in Sydney. CathRx has appointed numerous distributors in Europe to support the of sales of products which has begun.
Possible outcomes through to June 2010:
- re-focusing the Company’s sales forecast through expansion into new geographic markets & new products